Why find the needle in the haystack?
It is unclear whether or not subpatent malaria should be targeted for control of the disease. A new study further unravels the role of subpatent… Read more »
It is unclear whether or not subpatent malaria should be targeted for control of the disease. A new study further unravels the role of subpatent… Read more »
The recent Parasites and Vectors blog by Vera Unwin picked up on the attention given by the media to the encouraging announcements concerning the… Read more »
The latest results from the RTS,S Phase III trials have fuelled considerable excitement from the media, with talk of the… Read more »
With the announcement of approval to market for its new malaria medication SynriamTM the Indian pharmaceutical company Ranbaxy… Read more »
Over 1,300 cases of imported malaria have been reported in the UK annually for the past 10 years. A few of these unfortunate… Read more »